Cerity Partners; CNBC Halftime Report investment committee. A value-minded, long-term stock-picker — "pick your spots" patiently rather than trade the rotation. Running synthesis of his appearances, with per-transcript breakdowns and a stock index.
A "lag-7" hyperscaler — down on chip-input margin pressure, not fatally flawed; 25% margins can't go higher and expectations were too high, so the pullback is "a setup for the next leg higher."
The other named "lag-7" hyperscaler — same thesis as Amazon: margin pressure from chip-input inflation, intact cloud engine (Google Cloud +63%), pullback is a setup for the next leg higher.
Bought last week as "a value stock" at ~7× forward with rising estimates — the Citi/Adam-Parker "don't wait for a 5% pullback" logic and the refuse-to-buy-Nvidia-in-2023 analogy; cyclical but "middle innings."
Final-trade healthcare name — biopharma with the cystic-fibrosis franchise plus "other shots on goal"; his vehicle for healthcare going from "left for dead" to the hot sector.
Owns it; overbought after the Iran de-escalation rally with estimates flat — a long-term hold, but no new money and won't take the big tax hit to sell.
In one line: a value-leaning, long-term stock-picker who'd rather own his spots patiently than trade the factor rotation — the consumer is "the least of my worries" (gas down, jobs strong), the Mag-7 "lag-7" pullback is "a setup for the next leg higher," and Micron is a 7×-forward "value stock" in the "middle innings" of a cyclical upswing (the refuse-to-buy-Nvidia-in-2023 analogy).
Pick your spots, don't play the rotation. As a long-term holder he doesn't need to call value-vs-growth or equal-vs-cap-weight quarter to quarter — he accumulates in unloved sectors (healthcare went from "left for dead" to hot; energy is cold but pays you to wait via dividends/buybacks/valuation) on his own clock.
The "lag-7" is a setup, not a flaw. Amazon/Alphabet are down on chip-input margin pressure and over-high expectations, not a broken model; with margins already ~25% there's little room up, so the pullback is "a setup for the next leg higher." Strip the OpenAI/Anthropic one-off gains and tech still grew operating earnings ~25%.
Buy a cyclical on changed fundamentals + momentum — judge the inning. Micron at ~7× forward with rising estimates is "a value stock"; "up 600%, so what" is irrelevant once the fundamentals changed. It's cyclical, but "middle innings" — and strategic customer agreements may stretch the cycle. The entry rule: if you're only waiting for a 5% dip that may not come, you're admitting it's a buy here.
Hold overbought winners; don't take the tax hit. Delta is overbought (rallied on Iran de-escalation while estimates stayed flat) — nothing wrong, own it long-term, but no new money and no big-gain sale; re-check at earnings.
In media M&A, scale is the thesis. Consolidation is vibrant (Warner Bros + Paramount, Roku→Fox); a sub-scale spin (Comcast's NBCU) is "takeover bait," and "size and scale matter" — the lens through which he holds Disney.
Transcripts
One dated page per appearance — each has its full stock table, talking points, and the saved transcript. Newest first.